Mekonos Company
Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.
Technology:
Organ-on-a-chip
Industry:
Providers
Headquarters:
San Francisco, California, United States
Founded Date:
2017-05-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
17
Total Funding:
31000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-11-09
Last Funding Type:
Series A
Register and Claim Ownership